Lionhub Group Ltd (ASX:LHB) Insider Acquires A$180,000.00 in Stock

Share on StockTwits

Lionhub Group Ltd (ASX:LHB) insider Choon Keng (CK) Kho bought 3,600,000 shares of Lionhub Group stock in a transaction that occurred on Tuesday, August 6th. The stock was purchased at an average cost of A$0.05 ($0.04) per share, for a total transaction of A$180,000.00 ($127,659.57).

Choon Keng (CK) Kho also recently made the following trade(s):

  • On Wednesday, July 3rd, Choon Keng (CK) Kho bought 4,000,000 shares of Lionhub Group stock. The stock was purchased at an average cost of A$0.05 ($0.04) per share, for a total transaction of A$200,000.00 ($141,843.97).
  • On Friday, May 24th, Choon Keng (CK) Kho bought 3,700,000 shares of Lionhub Group stock. The stock was purchased at an average cost of A$0.05 ($0.04) per share, for a total transaction of A$185,000.00 ($131,205.67).

Shares of ASX:LHB opened at A$0.01 ($0.00) on Friday. The firm’s 50 day moving average price is A$0.01 and its 200 day moving average price is A$0.01. The stock has a market cap of $4.13 million and a price-to-earnings ratio of -1.00. Lionhub Group Ltd has a fifty-two week low of A$0.01 ($0.00) and a fifty-two week high of A$0.06 ($0.04). The company has a quick ratio of 0.00, a current ratio of 0.02 and a debt-to-equity ratio of 274.30.

Lionhub Group Company Profile

LionHub Group Limited, together with its subsidiaries, operates as a real estate development company in the People's Republic of China. It primarily develops technology parks. The company was formerly known as Arasor International Limited and changed its name to LionHub Group Limited in November 2013.

Recommended Story: What is the 52-week high/low?

Insider Buying and Selling by Quarter for Lionhub Group (ASX:LHB)

Receive News & Ratings for Lionhub Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lionhub Group and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Meridian Bioscience  Cut to Sell at ValuEngine
Meridian Bioscience Cut to Sell at ValuEngine
Trevena  Raised to “Buy” at Zacks Investment Research
Trevena Raised to “Buy” at Zacks Investment Research
2U  Now Covered by Analysts at William Blair
2U Now Covered by Analysts at William Blair
Aegis Reaffirms Buy Rating for Yield10 Bioscience
Aegis Reaffirms Buy Rating for Yield10 Bioscience
SunOpta, Inc.  Director Acquires $156,748.80 in Stock
SunOpta, Inc. Director Acquires $156,748.80 in Stock
First Majestic Silver Corp.  Senior Officer Sells C$179,375.00 in Stock
First Majestic Silver Corp. Senior Officer Sells C$179,375.00 in Stock


© 2006-2019 Ticker Report